Canaccord Genuity Group began coverage on shares of Perrigo in a report on Tuesday, March 7th.

Source: https://www.etfdailynews.com/2023/04/15/exchange-traded-concepts-llc-raises-stock-holdings-in-perrigo-company-plc-nyseprgo/

Finally, Personal CFO Solutions LLC lifted its holdings in Perrigo by 18.5% during the 2nd quarter.

Source: https://www.etfdailynews.com/2023/12/02/crawford-investment-counsel-inc-has-8-60-million-stake-in-perrigo-company-plc-nyseprgo/

Healthcare of Ontario Pension Plan Trust Fund cut its stake in shares of Perrigo Company plc () by 42.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.

Source: https://www.etfdailynews.com/2023/03/01/healthcare-of-ontario-pension-plan-trust-fund-has-568000-holdings-in-perrigo-company-plc-nyseprgo/

Perrigo acquired rights to the drug last year with its buyout of Paris-based HRA Pharma, which bought the pill from in 2014.

Source: https://fortune.com/well/2023/05/05/fda-over-the-counter-birth-control-opill/

Perrigo Co., a major manufacturer of infant formula, said this week it was making investments to modernize its production infrastructure and evaluating further changes, which will “significantly” raise costs.

Source: https://fortune.com/2023/05/10/baby-formula-prices-jump-record-high/

Perrigo Company plc has a fifty-two week low of $30.78 and a fifty-two week high of $41.44.

Source: https://www.dailypolitical.com/2023/09/02/profund-advisors-llc-boosts-stake-in-perrigo-company-plc-nyseprgo.html

The daily contraceptive Opill, sold by Perrigo, was first approved for prescription use in 1973, and the over-the-counter approval allows people to obtain it without first seeing a healthcare provider.

Source: https://gazette.com/news/us-world/fda-approves-first-over-the-counter-birth-control-pill-in-us/article_ff143171-dea2-5893-b50e-30f881654b02.html